444
Views
13
CrossRef citations to date
0
Altmetric
Clinical Trial Report

Hypnosis for the Management of Anxiety and Dyspnea in COPD: A Randomized, Sham-Controlled Crossover Trial

ORCID Icon, , , , ORCID Icon, , & show all
Pages 2609-2620 | Published online: 22 Oct 2020

References

  • Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2016 [homepage on the Internet]. Available from: http://goldcopd.org/. Accessed 105, 2020.
  • HanMK, MuellerovaH, Curran-EverettD, et al. GOLD 2011 disease severity classification in COPD gene: a prospective cohort study. Lancet Respir Med. 2013;1(1):43–50. doi:10.1016/S2213-2600(12)70044-924321803
  • PumarMI, GrayCR, WalshJR, YangIA, RollsTA, WardDL. Anxiety and depression-Important psychological comorbidities of COPD. J Thorac Dis. 2014;6(11):1615–1631. doi:10.3978/j.issn.2072-1439.2014.09.2825478202
  • HegerlU, MerglR. Depression and suicidality in COPD: understandable reaction or independent disorders? Eur Respir J. 2014;44(3):734–743. doi:10.1183/09031936.0019321324876171
  • KellnerR, SametJ, PathakD. Dyspnea, anxiety, and depression in chronic respiratory impairment. Gen Hosp Psychiatry. 1992;14(1):20–28. doi:10.1016/0163-8343(92)90022-31730397
  • MaurerJ, RebbapragadaV, BorsonS, et al. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest. 2008;134(4 Suppl):43S–56S. doi:10.1378/chest.08-034218842932
  • Di MarcoF, VergaM, ReggenteM, et al. Anxiety and depression in COPD patients: the roles of gender and disease severity. Respir Med. 2006;100(10):1767–1774. doi:10.1016/j.rmed.2006.01.02616531031
  • CafarellaPA, EffingTW, UsmaniZ, FrithPA. Treatments for anxiety and depression in patients with chronic obstructive pulmonary disease: A literature review. Respirology. 2012;17:627–638. doi:10.1111/j.1440-1843.2012.02148.x22309179
  • American Thoracic Society Committee on Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society. Am J Respir Crit Care Med. 1999;159(1):321–340. doi:10.1164/ajrccm.159.1.ats8989872857
  • ParshallMB, SchwartzsteinRM, AdamsL, et al.; American Thoracic Society Committee on Dyspnea. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012;185(4):435–452. doi:10.1164/rccm.201111-2042ST.22336677
  • BaşoğluM. Effective management of breathlessness: a review of potential human rights issues. Eur Respir J. 2017;49:1602099.28546267
  • TselebisA, PachiA, IliasI, et al. Strategies to improve anxiety and depression in patients with COPD: a mental health perspective. Neuropsychiatr Dis Treat. 2016;12:297–328. doi:10.2147/NDT.S7935426929625
  • SmithSMS, SonegoS, KetchesonL, et al. A review of the effectiveness of psychological interventions used for anxiety and depression in chronic obstructive pulmonary disease. BMJ Open Respir Res. 2014;1:e000042. doi:10.1136/bmjresp-2014-000042
  • HynninenM, BjerkeN, PallesenS, et al. A randomized controlled trial of cognitive behavioral therapy for anxiety and depression in COPD. Respir Med. 2010;104:986–994. doi:10.1016/j.rmed.2010.02.02020346640
  • LolakS, ConnorsG, SheridanMJ, WiseTN. Effects of progressive muscle relaxation training on anxiety and depression in patients enrolled in an outpatient pulmonary rehabilitation program. Psychother Psychosom. 2008;77:119–125. doi:10.1159/00011288918230945
  • VolpatoE, BanfiP, RogerSM, et al. Relaxation techniques for people with chronic obstructive pulmonary disease: a systematic review and a meta-analysis. Evid Based Complement Alternat Med. 2015;(2015):628365.26339268
  • VickersA, ZollmanC. ABC of complementary medicine. Hypnosis and relaxation therapies. BMJ. 1999;319:1346–1349. doi:10.1136/bmj.319.7221.134610567143
  • MontgomeryG, SucalaM, BaumT, SchnurJB. Hypnosis for symptom control in cancer patients at the end-of-life: a systematic review. Int J Clin Exp Hypn. 2017;65(3):296–307. doi:10.1080/00207144.2017.131472828506144
  • BrugnoliMP. Clinical hypnosis for palliative care in severe chronic diseases: a review and the procedures for relieving physical, psychological and spiritual symptoms. Ann Palliat Med. 2016;5(4):280–297. doi:10.21037/apm.2016.09.0427806624
  • KleinbubJR, PalmieriA, BroggioA, et al. Hypnosis-based psychodynamic treatment in ALS: a longitudinal study on patients and their caregivers. Front Psychol. 2015;6:822. doi:10.3389/fpsyg.2015.0082226136710
  • BrownD. Evidence-based hypnotherapy for asthma: a critical review. Int J Clin Exp Hypn. 2007;55(2):220–249. doi:10.1080/0020714060117794717427293
  • McBrideJ, VliegerA, AnbarR. Hypnosis in paediatric respiratory medicine. Paediatr Respir Rev. 2014;15(1):82–85. doi:10.1016/j.prrv.2013.09.00224534116
  • AnbarRD. Hypnosis for the treatment of functional respiratory disorders In: AnbarRD, editor. Functional Respiratory Disorders. Respiratory Medicine. Totowa, NJ: Humana Press; 2012. doi:10.1007/978-1-61779-857-3_12
  • ElkingtonH, WhiteP, Addington-HallJ, HiggsR, PettinaricC. The last year of life of COPD: a qualitative study of symptoms and services. Respir Med. 2004;98(5):439–445. doi:10.1016/j.rmed.2003.11.00615139573
  • MarteauT, BekkerH. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psychol. 1992;31:301–306. doi:10.1111/j.2044-8260.1992.tb00997.x1393159
  • SpielbergerCD. Manual for the State-Trait Anxiety Inventory STAI (Form Y). Palo Alto, CA: Consulting Psychologists Press; 1983.
  • GauthierL, BouchardS. A French-Canadian adaptation of the revised version of Spielberger’s state-trait anxiety inventory. Can J Behav Sci. 1993;25:559. doi:10.1037/h0078881
  • SmithI, MackayJ, FahridN, et al. Respiratory rate measurement a comparison of methods. Br J Healthc Assist. 2013;5(1):18–23. doi:10.12968/bjha.2011.5.1.18
  • JubranA, et al. Pulse oximetry In: PinskyMR, editor. Applied Physiology in Intensive Care Medicine. Berlin: Springer Verlag; 2006.
  • KendrickK, BaxiS, SmithR. Usefulness of the modified 0-10 Borg scale in assessing the degree of dyspnea in patients with COPD and asthma. J Emerg Nurs. 2000;26(3):216–222. doi:10.1016/S0099-1767(00)90093-X10839848
  • R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2013 ISBN 3-900051-07-0 Availabe from: http://www.R-project.org/. Accessed 105, 2020.
  • BatesD, MaechlerM, BolkerB, WalkerS. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015;67(1):1–48. doi:10.18637/jss.v067.i01
  • AgrestiA. Categorical Data Analysis. second ed. Wiley; 2002.
  • JaegerTF. Categorical data analysis: away from ANOVAs (transformation or not) and towards logit mixed models. J Mem Lang. 2008;59(4):434–446. doi:10.1016/j.jml.2007.11.00719884961
  • PinheiroJC, BatesDM. Mixed-Effects Models in S and SPLUS. New York: Springer; 2000.
  • BolkerB, BrooksM, ClarkC, et al. Generalized linear mixed models: a practical guide for ecology and evolution. Trends Ecol Evol. 2008;24(3).
  • FoxJ, WeisbergS. An {R} Companion to Applied Regression. Seconded. Thousand Oaks CA: Sage; 2011 Available from:: http://socserv.socsci.mcmaster.ca/jfox/Books/Companion. Accessed 105, 2020.
  • LenthR. Least-squares means: the R package lsmeans. J Stat Softw. 2016;69(1):1–33. doi:10.18637/jss.v069.i01
  • WagenmakersE, van der MaasH, GrasmanR. An EZ-diffusion model for response time and accuracy. Psychon Bull Rev. 2007;14(1):3–22. doi:10.3758/BF319402317546727
  • SchwarzG. Estimating the dimension of a model. Ann Stat. 1978;6:461–464. doi:10.1214/aos/1176344136
  • Morélot-PanziniC, AdlerD, AguilaniuB, et al. Breathlessness despite optimal pathophysiological treatment: on the relevance of being chronic. Eur Respir J. 2017;50(3):1701159. doi:10.1183/13993003.01159-201728954773
  • HayenA, HerigstadM, PattinsonKT. Understanding dyspnea as a complex individual experience. Maturitas. 2013;76(1):45–50. doi:10.1016/j.maturitas.2013.06.00523849705
  • TselebisA, BratisD, PachiA, et al. A pulmonary rehabilitation program reduces levels of anxiety and depression in COPD patients. Multidiscip Respir Med. 2013;8:41. doi:10.1186/2049-6958-8-4123931626
  • MorrisonJB. Chronic asthma and improvement with relaxation induced by hypnotherapy. J R Soc Med. 1988;81(12):701–704. doi:10.1177/0141076888081012073065498
  • ErenG, DoganY, DemirG, et al. Hypnosis for sedation in transesophageal echocardiography: a comparison with midazolam. Ann Saudi Med. 2015;35(1):58–63.26142940
  • DonnellCR, LansingRW, SchwartzsteinRM, BanzettR. The effect of aerosol saline on laboratory-induced dyspnea. Lung. 2017;195(1):37–42. doi:10.1007/s00408-016-9971-328004181
  • EsserRW, StoeckelMC, KirstenA, et al. Brain activation during perception and anticipation of dyspnea in chronic obstructive pulmonary disease. Front Physiol. 2017;8:617. doi:10.3389/fphys.2017.0061728878693
  • LynnSJ, MartinD, FraumanD. Does hypnosis pose special risks for negative effects? A master class commentary. Int J Clin Exp Hypn. 1996;44(1):7–19. doi:10.1080/002071496084160648582780
  • BrentarJ, LynnSJ. “Negative” effects and hypnosis: A critical examination. Br J Exp Clin Hypn. 1988;6:75–84.
  • BrentarJ, LynnSJ, CarlsonB, KurzhalsR. Controlled research on hypnotic aftereffects: the post-hypnotic experience questionnaire In: BongartzW, editor. Hypnosis 175 Years After Mesmer. Konstanz, Germany: University of Konstanz Press; 1992:179–201.
  • PetersenI, CoeW, CrockfordM, DeckerS Hypnotic sequelae revisited. Paper presented at the 99th annual convention of the American Psychological Association; San Francisco, USA; 1991.
  • SivecH, LynnSJ Negative posthypnotic effects: the influence of prehypnotic experiences. Paper presented at the 44th Annual Meeting of the Society for Clinical and Experimental Hypnosis, Arlington Heigths; IL, USA; 1993.
  • GandhiB, OakleyD. Does hypnosis by any other name smell as sweet? The efficacy of hypnotic inductions depends on the label « hypnosis ». Conscious Cogn. 2005;14:304–315. doi:10.1016/j.concog.2004.12.00415950884
  • TerhuneDB, CleeremansA, RazA, LynnSJ. Hypnosis and top-down regulation of consciousness. Neurosci Behav Rev. 2017;81:59–74. doi:10.1016/j.neubiorev.2017.02.002
  • van VlietLM, GodfriedMB, van DeelenGW, et al. Placebo effects of nurses’ communication alongside standard medical care on pain and other outcomes: a randomized controlled trial in clinical tonsillectomy care. Psychother Psychosom. 2020;89:56–58. doi:10.1159/00050390431655817
  • BarabaszA, OlnessK, BolandR, KahnS, Editors. Medical Hypnosis Primer, Clinical and Research Evidence. New York: Routledge; 2010.
  • KhairR, NwaneriC, DamicoR, KolbT, HassounP, MathaiS. The minimal important difference in Borg dyspnea score in pulmonary arterial hypertension; 2015.
  • Araujo OliveraA, AndradeL, MarquesA. Minimal clinically important difference and predictive validity of the mMRC and mBorg in acute exacerbations of COPD. Eur Respir J. 2017;50:PA4705. doi:10.1183/1393003.congress-2017.PA4705
  • StewartJ. Hypnosis in contemporary medicine. Mayo Clin Proc. 2005;80(4):511–524. doi:10.1016/S0025-6196(11)63203-515819289
  • EimerB. Inadvertent adverse consequences of clinical and forensic hypnosis: minimizing the risks. Am J Clin Hypn. 2012;55:8–31. doi:10.1080/00029157.2012.68607122913225
  • JulianLJ. Measures of anxiety: state‐trait anxiety inventory (STAI), Beck anxiety inventory (BAI), and hospital anxiety and depression scale‐anxiety (HADS‐A). Arthritis Care Res. 2011;63:S467–S472. doi:10.1002/acr.20561